NasdaqGS:AMGNBiotechs
Amgen (AMGN) Margin Expansion In Q1 2026 Tests Cautious Growth Narratives
Amgen (AMGN) opened 2026 with Q1 revenue of US$8.6 billion and basic EPS of US$3.37, setting the tone for how its earnings story is evolving after a year of stronger profitability. Over the past year, the company has seen trailing twelve month revenue move from US$33.4 billion to US$37.2 billion, while trailing EPS rose from US$7.62 to US$14.48, giving investors a clear view of how the earnings base has scaled alongside higher margins.
See our full analysis for Amgen.
With the latest quarter...